Antiemetic therapy: Management of chemotherapy-induced nausea and vomiting
- 31 May 1989
- journal article
- Published by Elsevier in Seminars in Oncology Nursing
- Vol. 5 (2) , 53-57
- https://doi.org/10.1016/0749-2081(89)90081-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy.Journal of Clinical Oncology, 1985
- Lorazepam in cancer patients treated with cisplatin: a drug having antiemetic, amnesic, and anxiolytic effects.Journal of Clinical Oncology, 1985
- Antiemetic Efficacy of DexamethasoneNew England Journal of Medicine, 1984
- Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study.Journal of Clinical Oncology, 1984
- Optimizing Metoclopramide Control of Cisplatin-Induced EmesisAnnals of Internal Medicine, 1984
- Extrapyramidal Reactions with High-Dose MetoclopramideNew England Journal of Medicine, 1983
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981
- Comparative Trial of the Antiemetic Effects of THC and HaloperidolThe Journal of Clinical Pharmacology, 1981
- Antiemetics in Patients Receiving Chemotherapy for CancerNew England Journal of Medicine, 1980
- Delta-9-Tetrahydrocannabinol as an Antiemetic for Patients Receiving Cancer ChemotherapyAnnals of Internal Medicine, 1979